Lorenz Muller
Corporate Officer/Principal chez MILESTONE PHARMACEUTICALS INC.
Fortune : 210 750 $ au 30/04/2024
Postes actifs de Lorenz Muller
Sociétés | Poste | Début | Fin |
---|---|---|---|
MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/10/2017 | - |
Historique de carrière de Lorenz Muller
Anciens postes connus de Lorenz Muller
Sociétés | Poste | Début | Fin |
---|---|---|---|
EXACT SCIENCES CORPORATION | Sales & Marketing | 01/06/2016 | 01/07/2017 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/07/2008 | 01/12/2015 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | 01/04/2001 | 02/05/2011 |
Formation de Lorenz Muller
Massachusetts Institute of Technology | Graduate Degree |
Harvard Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Canada | 2 |
Opérationnelle
Sales & Marketing | 2 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
EXACT SCIENCES CORPORATION | Health Technology |
MILESTONE PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 2 |
---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Bourse
- Insiders
- Lorenz Muller
- Expérience